Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Structural and syndemic barriers to PrEP adoption among Black women at high risk for HIV: a qualitative exploration.

Nydegger LA, Dickson-Gomez J, Ko TK.

Cult Health Sex. 2020 Mar 26:1-15. doi: 10.1080/13691058.2020.1720297. [Epub ahead of print]


An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia.

Ko TK, Javed A, Lee KL, Pathiraja TN, Liu X, Malik S, Soh SX, Heng XT, Takahashi N, Tan JHJ, Bhatia R, Khng AJ, Chng WJ, Sia YY, Fruman DA, Ng KP, Chan ZE, Xie KJ, Hoi Q, Chan CX, Teo ASM, Velazquez O, Meah WY, Khor CC, Ong CT, Soon WW, Tan P, Ng PC, Chuah C, Hillmer AM, Ong ST.

Blood. 2020 Mar 10. pii: blood.2020004834. doi: 10.1182/blood.2020004834. [Epub ahead of print]


CO Sensing Properties of Chemiresistive In₂O₃/SnO₂ Composite Nanoparticle Sensors.

Nam B, Ko TK, Hyun SK, Lee C.

J Nanosci Nanotechnol. 2020 Jul 1;20(7):4344-4348. doi: 10.1166/jnn.2020.17577.


NO2 sensing properties of WO3-decorated In2O3 nanorods and In2O3-decorated WO3 nanorods.

Nam B, Ko TK, Hyun SK, Lee C.

Nano Converg. 2019 Dec 13;6(1):40. doi: 10.1186/s40580-019-0205-2.


Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double-positive lung cancer.

Takeuchi S, Hase T, Shimizu S, Ando M, Hata A, Murakami H, Kawakami T, Nagase K, Yoshimura K, Fujiwara T, Tanimoto A, Nishiyama A, Arai S, Fukuda K, Katakami N, Takahashi T, Hasegawa Y, Ko TK, Ong ST, Yano S.

Cancer Sci. 2020 Feb;111(2):561-570. doi: 10.1111/cas.14260. Epub 2020 Jan 6.


The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia.

Rauzan M, Chuah CT, Ko TK, Ong ST.

PLoS One. 2017 Mar 16;12(3):e0174107. doi: 10.1371/journal.pone.0174107. eCollection 2017.


The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia.

Ko TK, Chin HS, Chuah CT, Huang JW, Ng KP, Khaw SL, Huang DC, Ong ST.

Oncotarget. 2016 Jan 19;7(3):2721-33. doi: 10.18632/oncotarget.5436.


Reply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia.

Ong ST, Chuah CT, Ko TK, Hillmer AM, Lim WT.

Nat Med. 2014 Oct;20(10):1090-1. doi: 10.1038/nm.3652. No abstract available.


Molecular and biochemical characteristics of β-propeller phytase from marine Pseudomonas sp. BS10-3 and its potential application for animal feed additives.

Nam SJ, Kim YO, Ko TK, Kang JK, Chun KH, Auh JH, Lee CS, Lee IK, Park S, Oh BC.

J Microbiol Biotechnol. 2014 Oct;24(10):1413-20.


Vertical InGaN light-emitting diode with a retained patterned sapphire layer.

Yang YC, Sheu JK, Lee ML, Yen CH, Lai WC, Hon SJ, Ko TK.

Opt Express. 2012 Nov 5;20(23):A1019-25.


Vertical InGaN light-emitting diode with a retained patterned sapphire layer.

Yang YC, Sheu JK, Lee ML, Yen CH, Lai WC, Hon SJ, Ko TK.

Opt Express. 2012 Nov 5;20 Suppl 6:A1019-25. doi: 10.1364/OE.20.0A1019.


A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer.

Ng KP, Hillmer AM, Chuah CT, Juan WC, Ko TK, Teo AS, Ariyaratne PN, Takahashi N, Sawada K, Fei Y, Soh S, Lee WH, Huang JW, Allen JC Jr, Woo XY, Nagarajan N, Kumar V, Thalamuthu A, Poh WT, Ang AL, Mya HT, How GF, Yang LY, Koh LP, Chowbay B, Chang CT, Nadarajan VS, Chng WJ, Than H, Lim LC, Goh YT, Zhang S, Poh D, Tan P, Seet JE, Ang MK, Chau NM, Ng QS, Tan DS, Soda M, Isobe K, Nöthen MM, Wong TY, Shahab A, Ruan X, Cacheux-Rataboul V, Sung WK, Tan EH, Yatabe Y, Mano H, Soo RA, Chin TM, Lim WT, Ruan Y, Ong ST.

Nat Med. 2012 Mar 18;18(4):521-8. doi: 10.1038/nm.2713.


Vertical InGaN light-emitting diodes with a sapphire-face-up structure.

Yang YC, Sheu JK, Lee ML, Tu SJ, Huang FW, Lai WC, Hon S, Ko TK.

Opt Express. 2012 Jan 2;20(1):A119-24.


Comparison of fentanyl and sufentanil added to 0.5% hyperbaric bupivacaine for spinal anesthesia in patients undergoing cesarean section.

Lee JH, Chung KH, Lee JY, Chun DH, Yang HJ, Ko TK, Yun WS.

Korean J Anesthesiol. 2011 Feb;60(2):103-8. doi: 10.4097/kjae.2011.60.2.103. Epub 2011 Feb 25.


Meralgia paresthetica affecting parturient women who underwent cesarean section -A case report-.

Chung KH, Lee JY, Ko TK, Park CH, Chun DH, Yang HJ, Gill HJ, Kim MK.

Korean J Anesthesiol. 2010 Dec;59 Suppl:S86-9. doi: 10.4097/kjae.2010.59.S.S86. Epub 2010 Dec 31.


Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.

Chang TL, Ito K, Ko TK, Liu Q, Salto-Tellez M, Yeoh KG, Fukamachi H, Ito Y.

Gastroenterology. 2010 Jan;138(1):255-65.e1-3. doi: 10.1053/j.gastro.2009.08.044. Epub 2009 Aug 23.


A review of development of cemeteries in Hong Kong: 1841-1950.

Ko TK.

J Hong Kong Branch R Asiat Soc. 2001;41:241-80. No abstract available.


RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.

Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, Inoue M, Putti TC, Loh M, Ko TK, Huang C, Bhalla KN, Zhu T, Ito Y, Sukumar S.

Cancer Res. 2006 Jul 1;66(13):6512-20.


Three different binding sites of Cks1 are required for p27-ubiquitin ligation.

Sitry D, Seeliger MA, Ko TK, Ganoth D, Breward SE, Itzhaki LS, Pagano M, Hershko A.

J Biol Chem. 2002 Nov 1;277(44):42233-40. Epub 2002 Jul 24.


CrkRS: a novel conserved Cdc2-related protein kinase that colocalises with SC35 speckles.

Ko TK, Kelly E, Pines J.

J Cell Sci. 2001 Jul;114(Pt 14):2591-603.


The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27.

Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, Hershko A.

Nat Cell Biol. 2001 Mar;3(3):321-4.


Supplemental Content

Support Center